In GBM, ADARB1-editing activity has been suggested to have a role in tumor suppression (38), but dysregulation of different ADARs in GSCs remains largely unknown, and the effects of specific altered editing event(s) that may functionally contribute to brain tumor development have not been identified. This evidence concerns the gene ADARB1 and glioblastoma.